|Role of sigma-1 receptors in neurodegenerative diseases|
L Nguyen, BP Lucke-Wold, SA Mookerjee, JZ Cavendish, MJ Robson, ...
Journal of pharmacological sciences 127 (1), 17-29, 2015
|Sigma receptors: potential targets for a new class of antidepressant drug|
JA Fishback, MJ Robson, YT Xu, RR Matsumoto
Pharmacology & therapeutics 127 (3), 271-282, 2010
|Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis|
FM Gengo, L Rubin, M Robson, M Rainka, MF Gengo, DE Mager, V Bates
The Journal of Clinical Pharmacology 48 (1), 117-122, 2008
|Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan|
L Nguyen, MJ Robson, JR Healy, AL Scandinaro, RR Matsumoto
PloS one 9 (2), e89985, 2014
|Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo|
MJ Robson, M Elliott, MJ Seminerio, RR Matsumoto
European Neuropsychopharmacology 22 (4), 308-317, 2012
|Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment?|
RC Turner, B Lucke-Wold, MJ Robson, B Omalu, AL Petraglia, JE Bailes
Frontiers in neurology 3, 186, 2013
|Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats|
RC Turner, ZJ Naser, AF Logsdon, KH DiPasquale, GJ Jackson, ...
Experimental neurology 248, 520-529, 2013
|Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events|
FM Gengo, M Rainka, M Robson, MF Gengo, A Forrest, M Hourihane, ...
The Journal of Clinical Pharmacology 48 (3), 335-343, 2008
|Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia|
RR Matsumoto, MJ Seminerio, RC Turner, MJ Robson, L Nguyen, ...
Pharmacology & therapeutics 144 (1), 28-40, 2014
|Sigma-1 receptors: potential targets for the treatment of substance abuse|
M J Robson, B Noorbakhsh, M J Seminerio, R R Matsumoto
Current pharmaceutical design 18 (7), 902-919, 2012
|Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities|
X Liu, DP Nemeth, DB McKim, L Zhu, DJ DiSabato, O Berdysz, G Gorantla, ...
Immunity 50 (2), 317-333. e6, 2019
|Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects|
RR Matsumoto, L Nguyen, N Kaushal, MJ Robson
Advances in Pharmacology 69, 323-386, 2014
|Immune system activation and depression: roles of serotonin in the central nervous system and periphery|
MJ Robson, MA Quinlan, RD Blakely
ACS chemical neuroscience 8 (5), 932-942, 2017
|Synthesis and pharmacological evaluation of indole-based sigma receptor ligands|
C Mésangeau, E Amata, W Alsharif, MJ Seminerio, MJ Robson, ...
European journal of medicinal chemistry 46 (10), 5154-5161, 2011
|Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms|
AF Logsdon, RC Turner, BP Lucke-Wold, MJ Robson, ZJ Naser, KE Smith, ...
Frontiers in cellular neuroscience 8, 421, 2014
|SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation|
MJ Robson, RC Turner, ZJ Naser, CR McCurdy, JD Huber, ...
Experimental neurology 247, 134-142, 2013
|SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation|
MJ Robson, RC Turner, ZJ Naser, CR McCurdy, JP O'Callaghan, ...
Experimental neurology 254, 180-189, 2014
|Alzheimer’s disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities|
RC Turner, BP Lucke-Wold, MJ Robson, JM Lee, JE Bailes
Brain injury 30 (11), 1279-1292, 2016
|The quest to model chronic traumatic encephalopathy: a multiple model and injury paradigm experience|
RC Turner, BP Lucke-Wold, AF Logsdon, MJ Robson, ML Dashnaw, ...
Frontiers in neurology 6, 222, 2015
|Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl) piperazin-1-yl) butyl) benzo [d] oxazol-2 (3H)-one (SN79), a cocaine antagonist, in rodents|
N Kaushal, MJ Robson, H Vinnakota, S Narayanan, BA Avery, ...
The AAPS journal 13 (3), 336-346, 2011